A Phase 4, Randomized, Double-Blind, Placebo-Controlled, Parallel Study of Ranolazine in Subjects With Chronic Stable Angina and Coronary Artery Disease With a History of Type 2 Diabetes Mellitus.

Trial Profile

A Phase 4, Randomized, Double-Blind, Placebo-Controlled, Parallel Study of Ranolazine in Subjects With Chronic Stable Angina and Coronary Artery Disease With a History of Type 2 Diabetes Mellitus.

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Mar 2017

At a glance

  • Drugs Ranolazine (Primary)
  • Indications Angina pectoris; Coronary artery disease
  • Focus Therapeutic Use
  • Acronyms TERISA
  • Sponsors Gilead Sciences
  • Most Recent Events

    • 26 Jul 2015 Results of a post hoc analysis published in the American Heart Journal.
    • 20 Nov 2013 Results reporting QoL and disease-specific health status presented at the 86th Annual Scientific Sessions of the American Heart Association.
    • 19 Nov 2013 Results of an analysis according to baseline HbA1c levels presented at the 86th Annual Scientific Sessions of the American Heart Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top